| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Kevin Schuyler is Director at VEEE and has filed Form 4s across 2 companies. Kevin Schuyler's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $327K at current prices.
Historically, Kevin Schuyler's trades have earned a below-average insider score of 23/100 across 4 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -33.4%.
The biggest single holding is VEEE (~$281K) as Director. Net of sales, the VEEE filings show accumulation of 26,363 shares.
Kevin Schuyler has 18 Form 4 filings on record from July 2018 to April 2026, across 2 companies: Director at Adial Pharmaceuticals (ADIL), 2018–2026; Director at Twin Vee Powercats (VEEE), 2022–2026.
The 45 reported transactions were 14 gifts, 12 other transactions, 10 option or other derivative awards and 6 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $15K and no sales.
The largest open-market purchase was 25,000 shares of VEEE at an average $0.41 on March 19, 2026, about $10K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | VEEE Twin Vee Powercats Co. | Director | Buy | 25,000 | $0.41 | $10,165.00 | +399.9% | -61.4% | - | |
| Sep 29, 2023 | ADIL Adial Pharmaceuticals, Inc. | Director | Buy | 700 | $2.74 | $1,918.00 | New | -36.3% | -63.7% | |
| Dec 22, 2022 | VEEE Twin Vee Powercats, Co. | Director | Buy | 1,363 | $1.78 | $2,427.77 | New | 0.0% | -17.0% | |
| Jul 31, 2018 | ADIL Adial Pharmaceuticals, Inc. | Director | Buy | 90,000 | $0.00 | - | +35.5% | - | - |